Aridis Pharmaceuticals
(OTC) ARDS
Aridis Pharmaceuticals Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$20.06M
Net Income (TTM)
-$1.14M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-39.70 (Low)
Dividend
$0.00
Beta (Volatility)
-39.70 (Low)
Price
$0.00
Volume
149,685
Open
$0.00
Price
$0.00
Volume
149,685
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
Jun 12, 2026
Dividend
$0.00
Beta (Volatility)
-39.70 (Low)
Price
$0.00
Volume
149,685
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
Jun 12, 2026
ARDS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aridis Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
37
CEO
Vu L. Truong, PhD
Website
www.aridispharma.comHeadquarters
Los Gatos, CA 95032, US
ARDS Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
164.69%
Return on Capital
N/A
Return on Assets
-209.25%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
44.57M
Volume
149.69K
Avg. Volume
18.99K
Financials (TTM)
Gross Profit
$20.06M
Operating Income
-$883.00K
EBITDA
-$574.00K
Operating Cash Flow
-$17.89M
Capital Expenditure
-$49.00K
Free Cash Flow
-$17.93M
Cash & ST Invst.
$35.00K
Total Debt
$4.84M
Aridis Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$417.00K
N/A
Gross Profit
$417.00K
N/A
Gross Margin
100.00%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
37
N/A
Net Income
-$83.00K
+99.1%
EBITDA
-$810.00K
+88.9%
Quarterly Fundamentals
Total Cash
$35.00K
-98.1%
Total Debt
$4.84M
-65.6%
Accounts Receivable
$517.00K
+108.5%
Inventory
$0.00
N/A
Long Term Debt
$854.00K
-82.7%
Short Term Debt
$3.99M
-56.4%
Return on Assets
-2.09%
N/A
Return on Invested Capital
1.35%
N/A
Free Cash Flow
-$983.00K
+77.0%
Operating Cash Flow
-$983.00K
+77.0%